A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer - PubMed

Affiliations

• PMID: 11916966
• DOI: 10.1074/jbc.M112231200

Free article

A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer

Huchun Li et al. J Biol Chem. 2002.

Free article

Abstract

Germ-line mutations in BRCA1 predispose individuals to breast and ovarian cancers. We observed a novel endogenous association of BRCA1 with Nmi (N-Myc-interacting protein) in breast cancer cells. Nmi was found to interact specifically with BRCA1, both in vitro and in vivo, by binding to two major domains in BRCA1, amino acid residues 298-683 and 1301-1863. Homodimerization of Nmi enhanced its association with BRCA1. Nmi functioned as an adaptor molecule to recruit c-Myc to a complex containing Nmi.c-Myc.BRCA1. Because c-Myc can activate transcription of the human telomerase reverse transcriptase gene (hTERT), we addressed the role of BRCA1 and Nmi in modulating c-Myc-induced hTERT promoter activity. Although Nmi or BRCA1 alone had no effect on c-Myc induced hTERT promoter activity, BRCA1 together with Nmi significantly inhibited this c-Myc induced hTERT promoter activity ( approximately 75% inhibition). Two mutated forms of BRCA1, a missense (A1708E) and a nonsense (Y1853X) that have been identified in familial breast cancers, associated with Nmi and c-Myc but failed to suppress c-Myc-induced hTERT promoter activity. These results demonstrate a novel pathogenic mechanism whereby mutations in BRCA1, via a novel transcription factor complex containing BRCA1, c-Myc, and Nmi, impair inhibition of c-Myc-induced hTERT promoter activity, which allows sustained activation of telomerase, a key enzyme in carcinogenesis.

Similar articles

• Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells.

  Zhou C, Liu J. Zhou C, et al. Biochem Biophys Res Commun. 2003 Mar 28;303(1):130-6. doi: 10.1016/s0006-291x(03)00318-8. Biochem Biophys Res Commun. 2003. PMID: 12646176

• ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs.

  Zhang F, Wang S, Zhu J. Zhang F, et al. J Biol Chem. 2020 Jul 17;295(29):10062-10075. doi: 10.1074/jbc.RA119.012130. Epub 2020 Jun 9. J Biol Chem. 2020. PMID: 32518154 Free PMC article.

• Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.

  Chen CJ, Kyo S, Liu YC, Cheng YL, Hsieh CB, Chan DC, Yu JC, Harn HJ. Chen CJ, et al. World J Gastroenterol. 2004 Mar 1;10(5):638-42. doi: 10.3748/wjg.v10.i5.638. World J Gastroenterol. 2004. PMID: 14991929 Free PMC article.

• Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.

  Kyo S, Takakura M, Fujiwara T, Inoue M. Kyo S, et al. Cancer Sci. 2008 Aug;99(8):1528-38. doi: 10.1111/j.1349-7006.2008.00878.x. Cancer Sci. 2008. PMID: 18754863 Free PMC article. Review.

• E2F1: a potential negative regulator of hTERT transcription in normal cells upon activation of oncogenic c-Myc.

  Zhang Y, Chen L, Yang S, Fang D. Zhang Y, et al. Med Sci Monit. 2012 Jan;18(1):RA12-15. doi: 10.12659/msm.882192. Med Sci Monit. 2012. PMID: 22207128 Free PMC article. Review.

Cited by

• NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.

  Katzenellenbogen RA, Egelkrout EM, Vliet-Gregg P, Gewin LC, Gafken PR, Galloway DA. Katzenellenbogen RA, et al. J Virol. 2007 Apr;81(8):3786-96. doi: 10.1128/JVI.02007-06. Epub 2007 Jan 31. J Virol. 2007. PMID: 17267499 Free PMC article.

• microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.

  Rostas JW 3rd, Pruitt HC, Metge BJ, Mitra A, Bailey SK, Bae S, Singh KP, Devine DJ, Dyess DL, Richards WO, Tucker JA, Shevde LA, Samant RS. Rostas JW 3rd, et al. Mol Cancer. 2014 Aug 29;13:200. doi: 10.1186/1476-4598-13-200. Mol Cancer. 2014. PMID: 25174825 Free PMC article.

• The functions and mechanisms of prefoldin complex and prefoldin-subunits.

  Liang J, Xia L, Oyang L, Lin J, Tan S, Yi P, Han Y, Luo X, Wang H, Tang L, Pan Q, Tian Y, Rao S, Su M, Shi Y, Cao D, Zhou Y, Liao Q. Liang J, et al. Cell Biosci. 2020 Jul 20;10:87. doi: 10.1186/s13578-020-00446-8. eCollection 2020. Cell Biosci. 2020. PMID: 32699605 Free PMC article. Review.

• Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.

  Ramlee MK, Wang J, Toh WX, Li S. Ramlee MK, et al. Genes (Basel). 2016 Aug 18;7(8):50. doi: 10.3390/genes7080050. Genes (Basel). 2016. PMID: 27548225 Free PMC article. Review.

• Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression.

  Li NF, Broad S, Lu YJ, Yang JS, Watson R, Hagemann T, Wilbanks G, Jacobs I, Balkwill F, Dafou D, Gayther SA. Li NF, et al. Cell Prolif. 2007 Oct;40(5):780-94. doi: 10.1111/j.1365-2184.2007.00462.x. Cell Prolif. 2007. PMID: 17877616 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc

• Miscellaneous

  • NCI CPTAC Assay Portal